The Heart of New Ulm: A Vision for the Future

  • Jackie L. Boucher
  • Raquel Franzini Pereira
  • Kevin J. Graham
  • Richard R. Pettingill
  • James V. Toscano
  • Timothy D. Henry
Article

Abstract

Coronary artery disease (CAD) continues to be a leading cause of death in the USA and throughout the world. Allina Health System, with the Minneapolis Heart Institute at Abbott Northwestern, recently announced a long-term study in the city of New Ulm, MN, to reduce risk factors for myocardial infarction and, ultimately, reduce myocardial infarction incidence. To achieve this goal, the focus will be on health promotion interventions and primary and secondary prevention strategies for CAD that are innovative, community-wide, and able to impact individuals at home, at work, in their community, and in their health care settings. Factors considered in selecting this city included the identification of health as a priority by the community, readiness and willingness of the community to change, the ability to provide and deliver systematic care, and partnerships established across multiple disciplines and sectors centered on improved health. The following stakeholders will be engaged: the community, employers, public health, health care, and health plans. Unique aspects of the intervention include centralized healthcare, including an automated medical record; genetic testing; integrated behavioral interventions; social environmental change and social circumstances; health promotion, primary prevention and secondary prevention interventions; advanced diagnostics and imaging; and state-of-the-art therapy.

Keywords

Cardiovascular Disease Community Intervention Prevention 

References

  1. 1.
    Lopez, A. D., Mathers, C. D., Jamison, D. T., & Murray, C. J. L. (2006). Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 367, 1747–1757.PubMedCrossRefGoogle Scholar
  2. 2.
    Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, S., et al. (2008). Heart disease and stroke statistics—2008 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation, 117, e25–e146.PubMedCrossRefGoogle Scholar
  3. 3.
    Wald, N. J., Law, M. R., Morris, J. K., & Jordan, R. (2003). Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. British Medical Journal, 326, 1427–1431.PubMedCrossRefGoogle Scholar
  4. 4.
    Blood Pressure Lowering Treatment Trialist’s Collaboration (2003). Effect of different blood pressure lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet, 362, 1527–1535.CrossRefGoogle Scholar
  5. 5.
    Law, M. R., Wald, N. J., & Rudnicka, A. (2003). Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease and stroke: systematic review and meta-analysis. British Medical Journal, 2003, 1423–1427.CrossRefGoogle Scholar
  6. 6.
    Antithrombotic Trialists’ Collaboration (2002). Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. British Medical Journal, 324, 71–86.CrossRefGoogle Scholar
  7. 7.
    Jones, D. W., Peterson, E. D., Bonow, R. O., Masoudi, F. A., Fonarow, G. C., Smith Jr., S. C., et al. (2008). Translating research into practice for healthcare providers. The American Heart Association's Strategy for Building Healthier Lives, Free of Cardiovascular Diseases and Stroke. Circulation, 118, 000–000.CrossRefGoogle Scholar
  8. 8.
    Henry, T. D., Sharkey, S. W., Burke, M. N., Chavez, I. J., Graham, K. J., Henry, C. R., et al. (2007). A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation, 116(7), 721–728.PubMedCrossRefGoogle Scholar
  9. 9.
    Lim, S. S., Gaziano, T. A., Gakidou, E., Reddy, K. S., Farzadfar, F., Lozano, R., et al. (2007). Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet, 370, 2054–2062.PubMedCrossRefGoogle Scholar
  10. 10.
    Mokdad, A. H., Marks, J. S., Stroup, J. S., & Gerberding, J. L. (2004). Actual causes of death in the United States, 2000. Journal of the American Medical Association, 291, 1238–1245 (Errata, JAMA 2005; 293–294, 298).PubMedCrossRefGoogle Scholar
  11. 11.
    Luepker, R. V., Murray, D. M., Jacobs, D. R., Mittelmark, M. B., Bracht, N., Carlaw, R., et al. (1994). Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. American Journal of Public Health, 84, 1383–1393.PubMedCrossRefGoogle Scholar
  12. 12.
    Brownson, R. C., Smith, C. A., Pratt, M., Mack, N. E., Jackson-Thompson, J., Dean, C. G., et al. (1996). Preventing cardiovascular disease through community-based risk reduction: the Bootheel Heart Health Project. American Journal of Public Health, 86, 206–213.PubMedCrossRefGoogle Scholar
  13. 13.
    Carleton, R. A., Lasater, T. M., Assaf, A. R., Feldman, H. A., McKinlay, S., & the Pawtucket Heart Health Program Writing Group (1995). The Pawtucket Heart Health Program: community changes in cardiovascular risk factors and projected disease risk. Journal of Public Health, 85, 777–785.CrossRefGoogle Scholar
  14. 14.
    Eaton, C. B., Lapane, K. L., Garber, C. E., Gans, K. M., Lasater, T. M., & Carleton, R. A. (1999). Effects of a community-based intervention on physical activity: The Pawtucket Heart Health Program. American Journal of Public Health, 89, 1741–1744.PubMedCrossRefGoogle Scholar
  15. 15.
    Barnett, E., Anderson, T., Blosnich, J., Halverson, J., & Novak, J. (2005). Promoting cardiovascular health: From individual goals to social environmental change. American Journal of Preventive Medicine, 29(5S1), 107–112.PubMedCrossRefGoogle Scholar
  16. 16.
    Puska, P., Salonen, J. T., Nissinen, A., Tuomilehto, J., Vartiainen, E., Korhonen, H., et al. (1983). Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). British Medical Journal, 287, 1840–1844.PubMedCrossRefGoogle Scholar
  17. 17.
    Puska, P., Pietnen, P., & Uusitalow, U. (2002). Influencing public nutrition for non-communicable disease prevention: from community intervention to national programme—experiences from Finland. Public Health Nutrition, 5, 245–251.Google Scholar
  18. 18.
    Mensah, G. A., Dietz, W. H., Harris, V. B., Henson, R., Labarthe, D. R., Vinicor, F., et al. (2005). Prevention and control of coronary heart disease and stroke—nomenclature for prevention approaches in public health. A statement for public health practice from the Centers for Disease Control and Prevention. American Journal of Preventive Medicine, 29(5S1), 152–157.PubMedCrossRefGoogle Scholar
  19. 19.
    Schroeder, S. A. (2007). We can do better—improving the health of American people. New England Journal of Medicine, 357, 1221–1228.PubMedCrossRefGoogle Scholar
  20. 20.
    McGinnis, J. M., & Goege, W. H. (1993). Actual causes of death in the United States. Journal of the American Medical Association, 270, 2207–2212.PubMedCrossRefGoogle Scholar
  21. 21.
    McGinnis, J. M., Williams-Russo, P., & Knickman, J. R. (2002). The case for active policy attention to health promotion. Health Affairs, 21(2), 28–93.CrossRefGoogle Scholar
  22. 22.
    Minnesota Department of Health (2008) Facts about heart disease and stroke in Minnesota. http://health.state.mn.us/divs/hpcd/chp/cvh/. Accessed 29 July 2008.
  23. 23.
    Pronk, N. P., & Boucher, J. (1999). Systems approach to childhood and adolescent obesity prevention and treatment in a managed care organization. International Journal of Obesity, 23, S38–S42.PubMedCrossRefGoogle Scholar
  24. 24.
    Trujillo, E., Davis, C., & Milner, J. (2006). Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. Journal of the American Dietetic Association, 106, 403–413.PubMedCrossRefGoogle Scholar
  25. 25.
    DeBusk, R. M., Fogarty, C. P., Ordovas, J. M., & Kornman, K. D. (2005). Nutritional genomics in practice: where do we begin? Journal of the American Dietetic Association, 105, 589–598.PubMedCrossRefGoogle Scholar
  26. 26.
    Matson-Koffman, D. M., Goetzel, R. Z., Anwuri, V. V., Shore, K. K., Orenstein, D., & LaPier, T. (2005). Heart healthy and stroke free: successful business strategies to prevent cardiovascular disease. American Journal of Preventive Medicine, 29(5S1), 113–121.PubMedCrossRefGoogle Scholar
  27. 27.
    Centers for Disease Control and Prevention (2004). Heart-healthy and smoke-free states: a communication plan for policy and environmental change. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.Google Scholar
  28. 28.
    Eyre, H., Kahn, R., Robertson, R. M., & with the ACS/ADA/AHA Collaborative Writing Committee (2004). Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation, 109, 3244–3255.PubMedCrossRefGoogle Scholar
  29. 29.
    Smith, S. C., Allen, J., Blair, S. N., Bonow, R. O., Brass, L. M., Fonarow, G. C., et al. (2006). AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation, 113, 2363–2372.PubMedCrossRefGoogle Scholar
  30. 30.
    Detrano, R., Guerci, A. D., Carr, J. J., Bild, D. E., Burke, G., Folsom, A. R., et al. (2008). Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New England Journal of Medicine, 358, 1336–1345.PubMedCrossRefGoogle Scholar
  31. 31.
    Pelzel, J. M., Lesser, J. F., Knickelbine, T., Flygenring, B., Tadros, G., & Schwartz, R. S. (2007). Multidetector CT coronary angiography: where we are and where we are going. Catheterization and Cariovascular Interventions, 69, 159–171.CrossRefGoogle Scholar
  32. 32.
    Hunt, A., Jacobs, A. K., Gibbons, R. J., Gregoratos, G., Halperin, J. L., Hiratzka, L. F., et al. (2004). ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation, 110, e82–e293.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Jackie L. Boucher
    • 1
  • Raquel Franzini Pereira
    • 1
  • Kevin J. Graham
    • 1
  • Richard R. Pettingill
    • 2
  • James V. Toscano
    • 1
  • Timothy D. Henry
    • 1
  1. 1.Minneapolis Heart Institute FoundationMinneapolisUSA
  2. 2.Allina Health SystemMinneapolisUSA

Personalised recommendations